These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 9389993)

  • 1. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly.
    Lombardi G; Colao A; Marzullo P; Ferone D; Longobardi S; Esposito V; Merola B
    J Endocrinol; 1997 Oct; 155 Suppl 1():S33-7; discussion S39. PubMed ID: 9389993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of growth hormone on cardiac function.
    Lombardi G; Colao A; Ferone D; Marzullo P; Orio F; Longobardi S; Merola B
    Horm Res; 1997; 48 Suppl 4():38-42. PubMed ID: 9350445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    Saccà L; Napoli R; Cittadini A
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiological aspects of growth hormone and insulin-like growth factor-I.
    Lombardi G; Colao A; Cuocolo A; Longobardi S; Di Somma C; Orio F; Merola B; Nicolai E; Salvatore M
    J Pediatr Endocrinol Metab; 1997; 10(6):553-60. PubMed ID: 9467124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study.
    Bogazzi F; Di Bello V; Palagi C; Donne MG; Di Cori A; Gavioli S; Talini E; Cosci C; Sardella C; Brogioni S; Mariani M; Martino E
    Clin Endocrinol (Oxf); 2005 May; 62(5):590-6. PubMed ID: 15853830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heart disease in acromegaly. Study of 27 patients].
    Marín F; Picó AM; Martínez JG; Domínguez JR; Alfayete R; Sogorb F
    Med Clin (Barc); 1996 Sep; 107(9):326-30. PubMed ID: 8984234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular complications in acromegaly.
    Vitale G; Pivonello R; Lombardi G; Colao A
    Minerva Endocrinol; 2004 Sep; 29(3):77-88. PubMed ID: 15282442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone and the heart.
    Colao A; Marzullo P; Di Somma C; Lombardi G
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):137-54. PubMed ID: 11207626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
    Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and metabolic effects of recombinant human growth hormone in cardiac insufficiency].
    Modlińska A; Babińska A; Faran G; Sworczak K
    Przegl Lek; 2003; 60(5):349-52. PubMed ID: 14593678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of dilated cardiomyopathy with recombinant human growth hormone].
    Osterziel KJ; Markus U; Willenbrock R; Strohm O; Dietz R
    Z Kardiol; 1997 Oct; 86(10):803-11. PubMed ID: 9454447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone and cardiac function.
    Lombardi G; Di Somma C; Marzullo P; Cerbone G; Colao A
    Ann Endocrinol (Paris); 2000 Feb; 61(1):16-21. PubMed ID: 10790587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone and the heart.
    Saccà L; Cittadini A; Fazio S
    Endocr Rev; 1994 Oct; 15(5):555-73. PubMed ID: 7843068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular consequences of early-onset growth hormone excess.
    Colao A; Spinelli L; Cuocolo A; Spiezia S; Pivonello R; di Somma C; Bonaduce D; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3097-104. PubMed ID: 12107207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients.
    Laursen T; Møller J; Fisker S; Jorgensen JO; Christiansen JS
    Growth Horm IGF Res; 1999 Dec; 9(6):451-7. PubMed ID: 10629166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac IGF-I manipulation by growth hormone following myocardial infarction.
    Matthews KG; Devlin GP; Stuart SP; Conaglen JV; Bass JJ
    Growth Horm IGF Res; 2004 Jun; 14(3):251-60. PubMed ID: 15125887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.